Brief: Cellceutix releases pharmacokinetics data from phase 2 trial of Prurisol
31/05/2016 12:00
May 31 (Reuters) - Cellceutix Corp CTIX.PK :
* Cellceutix releases pharmacokinetics data from phase 2
trial of Prurisol for treating psoriasis; data complements
efficacy data reported last week
Source text for Eikon: urn:newsml:reuters.com:*:nMKWlMG7ka
Further company coverage: CTIX.PK
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Innovation Pharmaceuticals
See all newsBrief: Innovation Pharmaceuticals Announces New Milestone At Beamed On Track To File 510(K) Submission To FDA In Q2 2024
Brief: Innovation Pharmaceuticals Provides Update On US Patent Applications Covering Use Of Brilacidin In Inflammatory Bowel Diseases, Coronaviruses And Fungal Diseases
Brief: Innovation Pharma Reports Enrollment In Phase 2 Trial Of Brilacidin For COVID-19 Tops 70%
Brief: Innovation Pharma Surpasses 50% Enrollment In Phase 2 Clinical Trial Of Brilacidin For COVID-19
Brief: Innovation Pharma Completes Interim Safety Data Review